Source: Cellular Molecular Neurobiology. Unidade: FCFRP
Assunto: FARMACOLOGIA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VISWANATHAN, M et al. [A25i]cgp 42112 reveals a non-angiotensin ii binding site in 1-methyl-4-phenylpyridine (mpp+)-induced brain injury. Cellular Molecular Neurobiology, v. 14, n. 1 , p. 99-104, 1994Tradução . . Acesso em: 20 maio 2024.APA
Viswanathan, M., Oliveira, A. M., Wu, R. M., Chiueh, C. C., & Saavedra, J. M. (1994). [A25i]cgp 42112 reveals a non-angiotensin ii binding site in 1-methyl-4-phenylpyridine (mpp+)-induced brain injury. Cellular Molecular Neurobiology, 14( 1 ), 99-104.NLM
Viswanathan M, Oliveira AM, Wu RM, Chiueh CC, Saavedra JM. [A25i]cgp 42112 reveals a non-angiotensin ii binding site in 1-methyl-4-phenylpyridine (mpp+)-induced brain injury. Cellular Molecular Neurobiology. 1994 ;14( 1 ): 99-104.[citado 2024 maio 20 ]Vancouver
Viswanathan M, Oliveira AM, Wu RM, Chiueh CC, Saavedra JM. [A25i]cgp 42112 reveals a non-angiotensin ii binding site in 1-methyl-4-phenylpyridine (mpp+)-induced brain injury. Cellular Molecular Neurobiology. 1994 ;14( 1 ): 99-104.[citado 2024 maio 20 ]
